{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030263","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.885477+00:00","generated_at":"2026-05-31T12:56:02.916396+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ainos Q2 2024 net loss widens to $3.2M; revenues nil; FCGS trial begins","bullets":["Revenues nil vs $28,555 YoY as COVID-19 test kit sales ceased; net loss $3,195,022 vs $2,349,727.","Cash $8,014,098 at June 30, 2024, after $9M convertible note in May and prepayment of senior secured note.","Enrolled first subject for VELDONA-based FCGS clinical study in July; 30-subject trial aims for Q1 2025 completion.","Next-Gen Ainos Flora VOC POCT with NVIDIA CUDA targets Q3 design completion, Q4 clinical trial kickoff.","Operating expenses rose to $3,023,636 from $2,289,336 YoY, driven by co-research, staff, and stock-based compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030263","json":"https://secwatch.observer/filing/0001493152-24-030263.json","markdown":"https://secwatch.observer/filing/0001493152-24-030263.md","text":"https://secwatch.observer/filing/0001493152-24-030263.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224030263/0001493152-24-030263-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224030263/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:56:02.916396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}